Intelligent bio solutions inc. announces exercise of previously issued warrants for $1.77 million in gross proceeds

New york, feb. 05, 2024 (globe newswire) -- intelligent bio solutions inc.  (nasdaq: inbs) ("inbs" or the "company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced an agreement between the company and several current warrant holders to exercise certain existing series e warrants (the “existing warrants”) to purchase up to an aggregate of 606,064 shares of common stock that were issued on october 4, 2023, in an underwritten public offering. the existing warrants have an exercise price of $2.9232 per share.
INBS Ratings Summary
INBS Quant Ranking